HGH FRAGMENT 176-191

HGH Fragment 176-191 | Roidbazaar

HGH Fragment 176-191 is a synthetic peptide corresponding to the C-terminal region of human growth hormone (hGH), specifically amino acids 176–191. This 16-amino acid sequence has attracted significant research interest for its potential role in lipid metabolism, particularly in studies examining lipolysis and fat mobilization without the broader systemic effects associated with full-length growth hormone .

For researchers and buyers sourcing HGH Fragment 176-191 through roidbazaar, this description covers the peptide’s molecular characteristics, research context, and key considerations for evaluating product quality.

What Is HGH Fragment 176-191?

HGH Fragment 176-191 is a peptide fragment derived from the C-terminal end of the human growth hormone molecule. Unlike full-length hGH, which binds to growth hormone receptors and triggers a cascade of effects including IGF-1 production, this fragment is theorized to interact selectively with metabolic pathways involved in fat breakdown .

The peptide sequence is: **Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe** with a disulfide bridge between Cys7 and Cys14 .

HGH Fragment 176-191 Research Context

Published research has explored **HGH Fragment 176-191** within several domains:

Lipid Metabolism Studies

Investigations suggest the peptide may influence lipolysis—the breakdown of stored triglycerides into free fatty acids—and potentially inhibit lipogenesis . These proposed mechanisms are theorized to occur without significant engagement of the growth hormone receptor pathway, distinguishing **HGH Fragment 176-191** from full-length hGH in research models .

Metabolic Signaling Pathways

Research indicates the fragment may interact with intracellular pathways related to cAMP signaling and enzymes such as hormone-sensitive lipase (HSL) . Scientists have hypothesized that **HGH Fragment 176-191** might modulate energy substrate preference in certain experimental systems .

Clinical Development History

The modified analog of HGH Fragment 176-191, known as AOD-9604, underwent clinical evaluation for obesity but did not receive FDA approval. Published human trial data is limited, and the compound is classified as research-only .

Why Researchers Search for HGH Fragment 176-191 on roidbazaar

**roidbazaar** serves as a listing platform where **HGH Fragment 176-191** and related research peptides are made available to the research community. Buyers searching for **HGH Fragment 176-191 on roidbazaar** typically seek:

– **Purity documentation** — HPLC and mass spectrometry data confirming peptide identity and purity
– **Accurate quantification** — verified peptide content per vial
– **Cold-chain compliance** — proper storage and shipping to maintain peptide stability
– **Batch traceability** — lot-specific Certificates of Analysis (COAs)

Evaluating **HGH Fragment 176-191** listings on **roidbazaar** requires the same scrutiny applied to any research peptide: label claims do not replace independent testing data .

—

HGH Fragment 176-191 — Quality Considerations

When assessing HGH Fragment 176-191 from any supplier including **roidbazaar**, researchers should verify:

1. **Purity (>95%)** — confirmed by HPLC analysis
2. **Molecular identity** — confirmed by mass spectrometry (expected: ~1815 Da)
3. **Peptide content** — distinguishes active peptide from counterions (TFA/acetate salts)
4. **Sterility** — for injectable research applications
5. **Storage conditions** — lyophilized peptide should be stored at -20°C, protected from light

Regulatory Status of HGH Fragment 176-191

HGH Fragment 176-191 is not FDA-approved for human therapeutic use. It is classified as a research compound. The World Anti-Doping Agency (WADA) lists **HGH Fragment 176-191** as a prohibited substance (S2 class) for competitive athletes . Researchers sourcing **HGH Fragment 176-191** through **roidbazaar** or any vendor should understand the regulatory and legal framework applicable in their jurisdiction.

Frequently Asked Questions: HGH Fragment 176-191 on roidbazaar

Q: What is HGH Fragment 176-191?
A: It is a 16-amino-acid peptide corresponding to residues 176–191 of human growth hormone, studied for potential metabolic applications in research settings .

Q: Is HGH Fragment 176-191 the same as AOD-9604?
A: AOD-9604 is a modified analog of HGH Fragment 176-191 with an additional tyrosine residue. They are related but structurally distinct compounds .

Q: Does HGH Fragment 176-191 raise IGF-1?
A: Preclinical research suggests it does not significantly elevate IGF-1 levels, unlike full-length growth hormone, because it lacks the receptor-binding region responsible for that effect .

Q: How should HGH Fragment 176-191 be stored?
A: Lyophilized **HGH Fragment 176-191** should be stored at -20°C for long-term stability, protected from light. Reconstituted peptide should be refrigerated and used within the timeframe specified by the supplier .

Q: Is HGH Fragment 176-191 available on roidbazaar?
A: **roidbazaar** lists research peptides including **HGH Fragment 176-191**. Buyers should verify batch-specific COAs and purity data before purchase.

Summary: HGH Fragment 176-191 and roidbazaar

HGH Fragment 176-191 is a research peptide derived from the C-terminal region of human growth hormone, investigated for its potential role in lipid metabolism and metabolic signaling pathways. Researchers sourcing **HGH Fragment 176-191** through **roidbazaar** should prioritize verifiable purity documentation, accurate quantification, and proper storage conditions. The compound is not approved for human therapeutic use and is classified as a prohibited substance by WADA.

 

Raw Material:	Fragment 176-191
Manufacturer:	DRIADA
Package:	1 vial (5mg/vial + 1ml Ampoule )